Sosei, AbbVie collaborate on new medicine for autoimmune diseases
The collaboration will leverage advanced StaR technology and SBDD platform to discover the advanced medicines that modulate GPCRs
Thermo Fisher, Daiichi Sankyo to co-develop CDx for Oncomine Dx target test
24 Jun 20Oncomine Dx Target Test identifies NSCLC in patients with human epidermal growth factor receptor 2 (HER2) mutations who…
GSK, Clover Biopharmaceuticals to initiate Covid-19 vaccine trials
22 Jun 20Clover will begin phase 1 study of GSK’s Covid-19 S-Trimer vaccine (SCB-2019) in combination with GSKs pandemic adjuvant…
AstraZeneca to supply 400 million doses of Covid-19 vaccine to Europe
15 Jun 20IVA is aimed at accelerating the supply of the vaccine and to ensure its availability to other European…
Thermo Fisher, Agios to co-develop companion diagnostic for LGG
10 Jun 20The partnership agreement encompasses identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System
AstraZeneca inks Covid-19 vaccine deal with CEPI, Gavi and SII
05 Jun 20Through the agreements, AstraZeneca aims to provide global access to the vaccine, including low and middle-income countries
Novavax selects AGC Biologics to produce Matrix-M adjuvant for NVX-CoV2373
04 Jun 20NVX-CoV2373 is a stable, prefusion protein designed by Novavax, leveraging its original nanoparticle technology, to work against SARS-CoV-2…
Thermo Fisher, CSL partner to address demand for biologic therapies
28 May 20Thermo Fisher will leverage its drug product development, biologics manufacturing, sterile fill-finish, packaging and clinical trials logistics to…
GSK, Samsung Biologics partner to expand biopharmaceutical manufacturing
22 May 20Samsung Biologics is expected to provide GSK with additional capacity for large-scale manufacture of biopharmaceutical products
CanSinoBIO, PNI to co-develop mRNA-LNP vaccine against Covid-19
21 May 20CanSinoBIO will hold rights to commercialise the vaccine product in Asia, except in Japan, while PNI will retain…